AsCNP/JSNP/JSCNP 2019

セッション情報

[AsCNP] ポスター発表 LBA

AsCNP » [AsCNP] ポスター発表 LBA

[AsCNP_LBA4] ポスター LBA 4
Depression 7

2019年10月11日(金) 13:40 〜 15:10 ポスター会場 (多目的ホール)

Chair: Yukihiko SHIRAYAMA (Teikyo University, Japan)

13:40 〜 13:45

Jung Goo LEE1, 2, 3, Ah Jeong CHOI1, Mi Kyoung SEO1, Sung Woo PARK1, 3, 4 (1. Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea., 2. Department of Psychiatry, College of Medicine, Haeundae Paik Hospital, Inje University, Busan, Republic of Korea., 3. Department of Health Science and Technology, Graduate School, Inje University, Busan, Republic of Korea., 4. Department of Convergence Biomedical Science, College of Medicine, Inje University, Busan, Republic of Korea.)

13:45 〜 13:50

Jung Goo LEE1, 2, 3, Ah Jeong CHOI1, Mi Kyoung SEO1, Sung Woo PARK1, 3, 4 (1. Paik Institute for Clinical Research, Inje University, Busan, Korea., 2. Department of Psychiatry, Inje University Haeundae Paik Hospital, Busan, Korea. , 3. Department of Health Science and Technology, Graduate School, Inje University, Korea., 4. Department of Convergence Biomedical Science, College of Medicine, Inje University, Busan, Korea.)

13:50 〜 13:55

Jung Goo LEE1, 2, 3, Ah Jeong CHOI1, Mi Kyoung SEO1, Sung Woo PARK1, 3, 4 (1. Paik Institute for Clinical Research, Inje University, Busan, Korea., 2. Department of Psychiatry, Inje University Haeundae Paik Hospital, Busan, Korea. , 3. Department of Health Science and Technology, Graduate School, Inje University, Korea., 4. Department of Convergence Biomedical Science, College of Medicine, Inje University, Busan, Korea.)

13:55 〜 14:00

Jung Goo LEE1, 2, 3, Ah Jeong CHOI1, Mi Kyoung SEO1, Sung Woo PARK1, 3, 4 (1. Paik Institute for Clinical Research, Inje University, Busan, Korea., 2. Department of Psychiatry, Inje University Haeundae Paik Hospital, Busan, Korea, 3. Department of Health Science and Technology, Graduate School, Inje University, Korea., 4. Department of Convergence Biomedical Science, College of Medicine, Inje University, Busan, Korea.)

14:05 〜 14:10

Yuko NAKATAKE1, 2, Misa YAMADA2, Hiroki FURUIE2, Kazumi YOSHIZAWA1, Mitsuhiko YAMADA2 (1. Laboratory of Pharmacology and Therapeutics, Graduate school of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan, 2. Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan)

14:10 〜 14:15

HIROSHI KUNIISHI1, Daisuke YAMADA2, Keiji WADA2, Mitsuhiko YAMADA1, Masayuki SEKIGUCHI2 (1. Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan, 2. Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan)